Capital World Investors Abb Vie Inc. Transaction History

Capital World Investors

$625 Billion
Q3 2024

A detailed history of Capital World Investors transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital World Investors holds 15,451,035 shares of ABBV stock, worth $2.8 Billion. This represents 0.49% of its overall portfolio holdings.

Number of Shares

15,451,035

Previous 10,283,579 50.25%

Holding current value

$2.8 Billion

Previous $1.76 Billion 72.99%

% of portfolio

0.49%

Previous 0.3%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $847 Million - $1.03 Billion	5,167,456 Added 50.25%	15,451,035 $3.05 Billion
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $915 Million - $1.07 Billion	5,910,395 Added 135.15%	10,283,579 $1.76 Billion
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $499 Million - $568 Million	3,120,310 Added 249.05%	4,373,184 $796 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $181 Million - $209 Million	-1,252,146 Reduced 49.99%	1,252,874 $200 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $198 Million - $238 Million	1,434,596 Added 134.02%	2,505,020 $405 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $144 Million - $165 Million	1,070,424 New	1,070,424 $144 Million
Q4 2019 Feb 18, 2020	SELL	$72.13 - $90.25 $548 Million - $686 Million	-7,601,408 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $21.1 Million - $25.4 Million	-335,524 Reduced 4.23%	7,601,408 $576 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $643 Million - $822 Million	-9,792,695 Reduced 55.23%	7,936,932 $577 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $123 Million - $145 Million	-1,593,555 Reduced 8.25%	17,729,627 $1.43 Billion
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $470 Million - $580 Million	-6,035,843 Reduced 23.8%	19,323,182 $1.78 Billion
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $965 Million - $1.07 Billion	10,858,432 Added 74.88%	25,359,025 $2.4 Billion
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $234 Million - $277 Million	-2,603,223 Reduced 15.22%	14,500,593 $1.34 Billion
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $103 Million - $138 Million	1,119,813 Added 7.01%	17,103,816 $1.62 Billion
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $70.1 Million - $76.9 Million	782,999 Added 5.15%	15,984,003 $1.55 Billion
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $1.06 Billion - $1.36 Billion	15,201,004	15,201,004 $1.35 Billion

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Abb Vie Inc. Transaction History